Although an in vitro screen revealed that low RIP3 levels rendered many HNSCC cell lines resistant to necroptosis, patient tumors maintained RIP3 expression and should therefore remain sensitive. The gene discussed is RIPK3; the disease is head and neck squamous cell carcinoma.